Judith A Aberg (Judith Aberg, Judy A Aberg)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 35

Top Topics

Respiratory Syndrome Coronavirus

Machine Learning

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Charlotte Hedskog, Christoph D Spinner, Ulrike Protzer, Dieter Hoffmann, Chunkyu Ko, Robert L Gottlieb, Medhat Askar, Meta Roestenberg, Jutte J C de Vries, Ellen C Carbo, Ross Martin, Jiani Li, Dong Han, Lauren Rodriguez, Aiyappa Parvangada, Jason K Perry, Ricard Ferrer, Andres Anton, Cristina Andrés, Vanessa Casares, Huldrych F Gunthard, Michael Huber, Grace A McComsey, Navid Sadri, Judith A Aberg, Harm van Bakel, Danielle P Porter
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials. Viruses 16 (4) (2024)
Francesca Cossarini, Joan Shang, Azra Krek, Zainab Al-Taie, Ruixue Hou, Pablo Canales-Herrerias, Minami Tokuyama, Michael Tankelevich, Adam Tillowiz, Divya Jha, Alexandra E Livanos, Louise Leyre, Mathieu Uzzan, Gustavo Martinez-Delgado, Matthew Tylor, Keshav Sharma, Arno R Bourgonje, Michael Cruz, Giorgio Ioannou, Travis Dawson, Darwin D'souza, Seunghee Kim-Schulze, Ahmed Akm, Judith A Aberg, Benjamin K Chen, Sacha Gnjatic, Alexandros D Polydorides, Andrea Cerutti, Carmen Argmann, Ivan Vujkovic-Cvijin, Mayte Suárez-Fariñas, Francesca Petralia, Jeremiah J Faith, Saurabh Mehandru
HIV-1 infection is associated with depletion of germinal center B cells and a decrease in IgA + plasma cells in the GI tract. bioRxiv : the preprint server for biology (2024)
Romit Bhattacharya, M D Mesbah Uddin, Aniruddh Pradip Patel, Abhishek Niroula, Phoebe Finneran, Rachel Bernardo, Kathleen V Fitch, Michael T Lu, Gerald S Bloomfield, Carlos D Malvestutto, Judith A Aberg, Carl J Fichtenbaum, Whitney E Hornsby, Heather J Ribaudo, Peter Libby, Benjamin L Ebert, Markella Zanni, Pamela S Douglas, Steven Grinspoon, Pradeep Natarajan
Risk Factors for Clonal Hematopoiesis of Indeterminate Potential in People with HIV: a report from the REPRIEVE Trial. Blood advances (2024)
Romit Bhattacharya, M D Mesbah Uddin, Aniruddh Pradip Patel, Abhishek Niroula, Phoebe Finneran, Rachel Bernardo, Kathleen V Fitch, Michael T Lu, Gerald S Bloomfield, Carlos D Malvestutto, Judith A Aberg, Carl J Fichtenbaum, Whitney E Hornsby, Heather J Ribaudo, Peter Libby, Benjamin L Ebert, Markella V Zanni, Pamela S Douglas, Steven K Grinspoon, Pradeep Natarajan
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial. Blood advances 8 (4) (2024)
Romit Bhattacharya, M D Mesbah Uddin, Aniruddh Pradip Patel, Abhishek Niroula, Phoebe Finneran, Rachel Bernardo, Kathleen V Fitch, Michael T Lu, Gerald S Bloomfield, Carlos D Malvestutto, Judith A Aberg, Carl J Fichtenbaum, Whitney E Hornsby, Heather J Ribaudo, Peter Libby, Benjamin L Ebert, Markella V Zanni, Pamela S Douglas, Steven K Grinspoon, Pradeep Natarajan
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial. Blood advances 8 (4) (2024)
Romit Bhattacharya, M D Mesbah Uddin, Aniruddh Pradip Patel, Abhishek Niroula, Phoebe Finneran, Rachel Bernardo, Kathleen V Fitch, Michael T Lu, Gerald S Bloomfield, Carlos D Malvestutto, Judith A Aberg, Carl J Fichtenbaum, Whitney E Hornsby, Heather J Ribaudo, Peter Libby, Benjamin L Ebert, Markella V Zanni, Pamela S Douglas, Steven K Grinspoon, Pradeep Natarajan
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial. Blood advances 8 (4) (2024)
Romit Bhattacharya, M D Mesbah Uddin, Aniruddh Pradip Patel, Abhishek Niroula, Phoebe Finneran, Rachel Bernardo, Kathleen V Fitch, Michael T Lu, Gerald S Bloomfield, Carlos D Malvestutto, Judith A Aberg, Carl J Fichtenbaum, Whitney E Hornsby, Heather J Ribaudo, Peter Libby, Benjamin L Ebert, Markella V Zanni, Pamela S Douglas, Steven K Grinspoon, Pradeep Natarajan
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial. Blood advances 8 (4) (2024)
Charlotte Hedskog, Christoph D Spinner, Ulrike Protzer, Dieter Hoffmann, Chunkyu Ko, Robert L Gottlieb, Medhat Askar, Meta Roestenberg, Jutte J C de Vries, Ellen C Carbo, Ross Martin, Jiani Li, Dong Han, Lauren Rodriguez, Aiyappa Parvangada, Jason K Perry, Ricard Ferrer, Andres Anton, Cristina Andrés, Vanessa Casares, Huldrych F Gunthard, Michael Huber, Grace A McComsey, Navid Sadri, Judith A Aberg, Harm van Bakel, Danielle P Porter
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials. Viruses 16 (4) (2024)
Charlotte Hedskog, Christoph D Spinner, Ulrike Protzer, Dieter Hoffmann, Chunkyu Ko, Robert L Gottlieb, Medhat Askar, Meta Roestenberg, Jutte J C de Vries, Ellen C Carbo, Ross Martin, Jiani Li, Dong Han, Lauren Rodriguez, Aiyappa Parvangada, Jason K Perry, Ricard Ferrer, Andres Anton, Cristina Andrés, Vanessa Casares, Huldrych F Gunthard, Michael Huber, Grace A McComsey, Navid Sadri, Judith A Aberg, Harm van Bakel, Danielle P Porter
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials. Viruses 16 (4) (2024)
Charlotte Hedskog, Christoph D Spinner, Ulrike Protzer, Dieter Hoffmann, Chunkyu Ko, Robert L Gottlieb, Medhat Askar, Meta Roestenberg, Jutte J C de Vries, Ellen C Carbo, Ross Martin, Jiani Li, Dong Han, Lauren Rodriguez, Aiyappa Parvangada, Jason K Perry, Ricard Ferrer, Andres Anton, Cristina Andrés, Vanessa Casares, Huldrych F Gunthard, Michael Huber, Grace A McComsey, Navid Sadri, Judith A Aberg, Harm van Bakel, Danielle P Porter
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials. Viruses 16 (4) (2024)
Romit Bhattacharya, M D Mesbah Uddin, Aniruddh Pradip Patel, Abhishek Niroula, Phoebe Finneran, Rachel Bernardo, Kathleen V Fitch, Michael T Lu, Gerald S Bloomfield, Carlos D Malvestutto, Judith A Aberg, Carl J Fichtenbaum, Whitney E Hornsby, Heather J Ribaudo, Peter Libby, Benjamin L Ebert, Markella V Zanni, Pamela S Douglas, Steven K Grinspoon, Pradeep Natarajan
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial. Blood advances 8 (4) (2024)
Romit Bhattacharya, M D Mesbah Uddin, Aniruddh Pradip Patel, Abhishek Niroula, Phoebe Finneran, Rachel Bernardo, Kathleen V Fitch, Michael T Lu, Gerald S Bloomfield, Carlos D Malvestutto, Judith A Aberg, Carl J Fichtenbaum, Whitney E Hornsby, Heather J Ribaudo, Peter Libby, Benjamin L Ebert, Markella V Zanni, Pamela S Douglas, Steven K Grinspoon, Pradeep Natarajan
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial. Blood advances 8 (4) (2024)
Romit Bhattacharya, M D Mesbah Uddin, Aniruddh Pradip Patel, Abhishek Niroula, Phoebe Finneran, Rachel Bernardo, Kathleen V Fitch, Michael T Lu, Gerald S Bloomfield, Carlos D Malvestutto, Judith A Aberg, Carl J Fichtenbaum, Whitney E Hornsby, Heather J Ribaudo, Peter Libby, Benjamin L Ebert, Markella V Zanni, Pamela S Douglas, Steven K Grinspoon, Pradeep Natarajan
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial. Blood advances 8 (4) (2024)
Sean T H Liu, Mila Mirceta, Grace Lin, Deborah M Anderson, Tarashon Broomes, Alina Jen, Ashley Abid, David Reich, Christine Hall, Judith A Aberg
Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 Study. Antimicrobial agents and chemotherapy (2023)
Sean T H Liu, Mila Mirceta, Grace Lin, Deborah M Anderson, Tarashon Broomes, Alina Jen, Ashley Abid, David Reich, Christine Hall, Judith A Aberg
Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 Study. Antimicrobial agents and chemotherapy 67 (3) (2023)
Hung-Mo Lin, Sean T H Liu, Matthew A Levin, John Williamson, Nicole M Bouvier, Judith A Aberg, David Reich, Natalia Egorova
Informative Censoring-A Cause of Bias in Estimating COVID-19 Mortality Using Hospital Data. Life (Basel, Switzerland) 13 (1) (2023)
Umesh G Lalloo, Lauren Komarow, Judith A Aberg, David B Clifford, Evelyn Hogg, Ashley McKhann, Aggrey Bukuru, David Lagat, Sandy Pillay, Vidya Mave, Khuanchai Supparatpinyo, Wadzanai Samaneka, Deborah Langat, Eduardo Ticona, Sharlaa Badal-Faesen, Robert A Larsen, null null
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group. PloS one 18 (2) (2023)
Sean T H Liu, Mila Mirceta, Grace Lin, Deborah M Anderson, Tarashon Broomes, Alina Jen, Ashley Abid, David Reich, Christine Hall, Judith A Aberg
Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 Study. Antimicrobial agents and chemotherapy 67 (3) (2023)
Talia H Swartz, Judith A Aberg
Preserving the Future of ID: Why We Must Address the Decline in Compensation for Clinicians and Researchers. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Judith A Aberg, Anthony Mills, Santiago Moreno, Jill Slater, Manyu Prakash, Andrew Clark
The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical review. Antiviral therapy 28 (3) (2023)
Hung-Mo Lin, Sean T H Liu, Matthew A Levin, John Williamson, Nicole M Bouvier, Judith A Aberg, David Reich, Natalia Egorova
Informative Censoring-A Cause of Bias in Estimating COVID-19 Mortality Using Hospital Data. Life (Basel, Switzerland) 13 (1) (2023)
Umesh G Lalloo, Lauren Komarow, Judith A Aberg, David B Clifford, Evelyn Hogg, Ashley McKhann, Aggrey Bukuru, David Lagat, Sandy Pillay, Vidya Mave, Khuanchai Supparatpinyo, Wadzanai Samaneka, Deborah Langat, Eduardo Ticona, Sharlaa Badal-Faesen, Robert A Larsen, null null
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group. PloS one 18 (2) (2023)
Hung-Mo Lin, Sean T H Liu, Matthew A Levin, John Williamson, Nicole M Bouvier, Judith A Aberg, David Reich, Natalia Egorova
Informative Censoring-A Cause of Bias in Estimating COVID-19 Mortality Using Hospital Data. Life (Basel, Switzerland) 13 (1) (2023)
Umesh G Lalloo, Lauren Komarow, Judith A Aberg, David B Clifford, Evelyn Hogg, Ashley McKhann, Aggrey Bukuru, David Lagat, Sandy Pillay, Vidya Mave, Khuanchai Supparatpinyo, Wadzanai Samaneka, Deborah Langat, Eduardo Ticona, Sharlaa Badal-Faesen, Robert A Larsen, null null
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group. PloS one 18 (2) (2023)
Sean T H Liu, Mila Mirceta, Grace Lin, Deborah M Anderson, Tarashon Broomes, Alina Jen, Ashley Abid, David Reich, Christine Hall, Judith A Aberg
Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 Study. Antimicrobial agents and chemotherapy 67 (3) (2023)
Sean T H Liu, Mila Mirceta, Grace Lin, Deborah M Anderson, Tarashon Broomes, Alina Jen, Ashley Abid, David Reich, Christine Hall, Judith A Aberg
Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 Study. Antimicrobial agents and chemotherapy 67 (3) (2023)
Talia H Swartz, Judith A Aberg
Collaborative Strategies for Antimicrobial Stewardship Programs: Navigating Financial and Regulatory Landscapes. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Robert P Hirten, Matteo Danieletto, Lewis E Tomalin, Katie Hyewon Choi, Micol Zweig, Eddye A Golden, Sparshdeep Kaur, Drew S Helmus, Anthony Biello, Renata Pyzik, Alexander W Charney, Riccardo Miotto, Benjamin Scott Glicksberg, Matthew A Levin, Ismail Nabeel, Judith A Aberg, David L Reich, Dennis S Charney, Erwin P Böttinger, Laurie Keefer, Mayte Suárez-Fariñas, Girish Nitin Nadkarni, Zahi Adel Fayad
Use of Physiological Data From a Wearable Device to Identify SARS-CoV-2 Infection and Symptoms and Predict COVID-19 Diagnosis: Observational Study. Journal of medical Internet research 23 (2) (2021)
Akhil Vaid, Sulaiman S Somani, Adam J Russak, Jessica K De Freitas, Fayzan F Chaudhry, Ishan Paranjpe, Kipp W Johnson, Samuel J Lee, Riccardo Miotto, Felix Richter, Shan P Zhao, Noam D Beckmann, Nidhi Naik, Arash Kia, Prem Timsina, Anuradha Lala, Manish D Paranjpe, Eddye A Golden, Matteo Danieletto, Manbir Singh, Dara Meyer, Paul F O'Reilly, Laura M Huckins, Patricia Kovatch, Joseph Finkelstein, Robert M Freeman, Edgar Argulian, Andrew Kasarskis, Bethany L Percha, Judith A Aberg, Emilia Bagiella, Carol R Horowitz, Barbara Murphy, Eric J Nestler, Eric E Schadt, Judy H Cho, Carlos Cordon-Cardo, Valentin Fuster, Dennis S Charney, David L Reich, Erwin P Böttinger, Matthew A Levin, Jagat Narula, Zahi Adel Fayad, Allan Carpenter Just, Alexander W Charney, Girish Nitin Nadkarni, Benjamin Scott Glicksberg
Machine Learning to Predict Mortality and Critical Events in a Cohort of Patients With COVID-19 in New York City: Model Development and Validation. Journal of medical Internet research 22 (11) (2020)
Ana Silvia Gonzalez-Reiche, Matthew M Hernandez, Mitchell J Sullivan, Brianne Ciferri, Hala Alshammary, Ajay Obla, Shelcie Fabre, Giulio Kleiner, Jose Polanco, Zenab Khan, Bremy Alburquerque, Adriana van de Guchte, Jayeeta Dutta, Nancy J Francoeur, Betsaida Salom Melo, Irina Oussenko, Gintaras Deikus, Juan Soto, Shwetha Hara Sridhar, Ying-Chih Wang, Kathryn Twyman, Andrew Kasarskis, Deena R Altman, Melissa Laird Smith, Robert Sebra, Judith A Aberg, Florian Krammer, Adolfo García-Sastre, Marta Luksza, Gopi Patel, Alberto Paniz Mondolfi, Melissa Randy Gitman, Emilia Mia Sordillo, Viviana Simon, Harm van Bakel
Introductions and early spread of SARS-CoV-2 in the New York City area. Science (New York, N.Y.) 369 (6501) (2020)
Diane Marie Del Valle, Seunghee Kim-Schulze, Hsin-Hui Huang, Noam D Beckmann, Sharon Nirenberg, Bo Wang, Yonit Lavin, Talia H Swartz, Deepu Madduri, Aryeh Stock, Thomas U Marron, Hui Xie, Manishkumar Patel, Kevin Tuballes, Oliver Van Oekelen, Adeeb Rahman, Patricia Kovatch, Judith A Aberg, Eric Schadt, Sundar Jagannath, Madhu Mazumdar, Alexander W Charney, Adolfo Firpo-Betancourt, Damodara Rao Mendu, Jeffrey Jhang, David Reich, Keith Sigel, Carlos Cordon-Cardo, Marc Feldmann, Samir Parekh, Miriam Merad, Sacha Gnjatic
An inflammatory cytokine signature predicts COVID-19 severity and survival. Nature medicine 26 (10) (2020)
Sean T H Liu, Hung-Mo Lin, Ian Baine, Ania Wajnberg, Jeffrey P Gumprecht, Farah Rahman, Denise Rodriguez, Pranai Tandon, Adel Bassily-Marcus, Jeffrey Bander, Charles Sanky, Amy Dupper, Allen Zheng, Freddy T Nguyen, Fatima Amanat, Daniel Stadlbauer, Deena R Altman, Benjamin K Chen, Florian Krammer, Damodara Rao Mendu, Adolfo Firpo-Betancourt, Matthew A Levin, Emilia Bagiella, Arturo Casadevall, Carlos Cordon-Cardo, Jeffrey S Jhang, Suzanne A Arinsburg, David L Reich, Judith A Aberg, Nicole M Bouvier
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study. Nature medicine 26 (11) (2020)
Ania Wajnberg, Fatima Amanat, Adolfo Firpo, Deena R Altman, Mark J Bailey, Mayce Mansour, Meagan McMahon, Philip Meade, Damodara Rao Mendu, Kimberly A Muellers, Daniel Stadlbauer, Kimberly Stone, Shirin Strohmeier, Viviana Simon, Judith A Aberg, David L Reich, Florian Krammer, Carlos Cordon-Cardo
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science (New York, N.Y.) 370 (6521) (2020)
Mathieu Uzzan, Minami Tokuyama, Adam K Rosenstein, Costin Tomescu, Ivo Novita Sah Bandar, Huaibin Mabel Ko, Louise Leyre, Anupa Chokola, Emma Kaplan-Lewis, Gabriela Rodriguez, Akihiro Seki, Michael J Corley, Judith A Aberg, Annalena La Porte, Eun-Young Park, Hideki Ueno, Ioannis Oikonomou, Itai Doron, Iliyan D Iliev, Benjamin K Chen, Jennifer Lui, Timothy W Schacker, Glaucia C Furtado, Sergio A Lira, Jean-Frederic Colombel, Amir Horowitz, Ee Jean Lim, Nicolas Chomont, Adeeb H Rahman, Luis J Montaner, Lishomwa C Ndhlovu, Saurabh Mehandru
Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals. Science translational medicine 10 (461) (2019)
Meagan P O'Brien, M Urooj Zafar, Jose C Rodriguez, Ibeawuchi Okoroafor, Alex Heyison, Karen Cavanagh, Gabriela Rodriguez-Caprio, Alan Weinberg, Gines Escolar, Judith A Aberg, Juan José Badimon
Targeting thrombogenicity and inflammation in chronic HIV infection. Science advances 5 (6) (2019)